CAS: 6998-60-3; Rifamycin

结构式图片

MSDS等安全信息

    上下游产品

    rifamycin S rifamycin B rifamycin S 39H48N2O14C39H48N2O14rifamycin S Rifamycin S 3-Bromrifamycin S 46H55NO13SC46H55NO13S

    合成工艺路线路线简述

      利福霉素置于甲醇,利福霉素,维生素 C,水,Final Solution,利福霉素体系中,用 Rifamycin B-<4-Jod-Anilid> 作为反应溶剂,化学反应 55.0H,以2.4 Gr Of Deep Yellowish Rifamycin Sv Crystals Were Obtained的收率获得产物利福霉素
      参考文献:Biological Process For The Preparation Of Rifamycin Derivatives
      标题:Biological Process For The Preparation Of Rifamycin Derivatives
      摘要:提供一种通过使用humicola Spp.(atcc 20620)或monocillium Spp.(atcc 20621)的整个细胞,细胞提取物或固定化酶将利福霉素b转化为利福霉素o,利福霉素s或利福霉素sv的生物过程.该过程还包括将转化为利福霉素o,利福霉素s或利福霉素sv的利福霉素b从发酵液中回收.

      海关参考信息

      专利信息


      专利号:US-4557866-A
      优先权日:1984-05-15
      标 题 :Process for the synthesis of pyrido-imidazo rifamycins
      发明人:CANNATA VINCENZO; TAMAGNONE GIAN F
      权利人:ALFA FARMACEUTICI SPA
      摘要:A new process for the synthesis of pyrido-imidazo-rifamycins of formula I wherein R is hydrogen or acetyl, R1 and R2 independently represent hydrogen, (C1-4)-alkyl, benzyloxy, mono- or di-(C1-3)-alkylamino-(C1-4)-alkyl, (C1-3)-alkoxy-(C1-4)-alkyl, hydroxymethyl, hydroxy-(C2-4)-alkyl, cyano, halogen, nitro, mercapto, (C1-4)-alkylthio, phenylthio, carbamoyl, mono- or di-(C1-4)-alkyl-carbamoyl, or R1 and R2 taken together with two consecutive carbon atoms of the pyridine nucleus form a benzene ring optionally substituted by one or two methyl or ethyl groups. The process comprises reacting the rifamycin O of formula II with a 2-aminopyridine of formula III wherein R1 and R2 have the same meanings as before.

      专利号:US-11851651-B2
      优先权日:2017-06-19
      标 题 :Automated methods for scalable, parallelized enzymatic biopolymer synthesis and modification using microfluidic devices
      发明人:BANAL JAMES; BERLEANT JOSEPH DON; SHEPHERD TYSON; BATHE MARK
      权利人:MASSACHUSETTS INST TECHNOLOGY
      摘要:Methods for the automated template-free synthesis of user-defined sequence controlled biopolymers using microfluidic devices are described. The methods facilitate simultaneous synthesis of up to thousands of uniquely addressed biopolymers from the controlled movement and combination of regents as fluid droplets using microfluidic and EWOD-based systems. In some forms, biopolymers including nucleic acids, peptides, carbohydrates, and lipids are synthesized from step-wise assembly of building blocks based on a user-defined sequence of droplet movements. In some forms, the methods synthesize uniquely addressed nucleic acids of up to 1,000 nucleotides in length. Methods for adding, removing and changing barcodes on biopolymers are also provided. Biopolymers synthesized according to the methods, and libraries and databases thereof are also described. Modified biopolymers, including chemically modified nucleotides and biopolymers conjugated to other molecules are described.

      专利号:US-2002192767-A1
      优先权日:1999-10-13
      标题 :Biosynthesis of polyketide synthase substrates
      发明人:KHOSLA CHAITAN; PFEIFER BLAINE
      摘要:The use of enzymes which catalyze the production of starter and extender units for polyketides is described. In addition, modified loading modules are described, which can accept a variety of starting units such as substituted benzoates, and which can be used to generate substituted derivatives of natural products. These enzymes may be used to enhance the yield of polyketides that are natively produced or polyketides that are rationally designed. By using these techniques, the synthesis of a complete polyketide has been achieved in E. coli . Production can be enhanced in microbial organisms of polyketides and other secondary metabolites by delaying production until after exponential phase and by maintaining relatively constant nutrient levels in the medium. In addition, polyketide production can be enhanced by providing an expression system for a thioesterase II. Thus, by modifying the host organism and changing the culture conditions, synthesis of a secondary metabolite can be enhanced. The present invention also results in a host organism with desirable characteristics to be used in the production of such polyketides and to assess the results of gene shuffling.

      专利号:US-7595156-B2
      优先权日:2003-10-23
      标 题:Genes for synthesis of FR-008 polyketides
      发明人:LEE SANG YUP; DENG ZIXIN; CHEN SHI; JEONG KI JUN; ZHOU XIUFEN
      权利人:KOREA ADVANCED INST SCI & TECH
      摘要:The present invention relates to the base sequence of whole genes involved in the biosynthesis of FR-008 polyketides derived from Streptomyces sp. FR-008. This base sequence comprises genes coding for ketosynthase (KS), acyl transferase (AT), acyl carrier protein (ACP), ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, sugar synthetic protein, FAD-dependent monooxygenase, 4-amino-4-deoxychorismate (ADC) synthase and ADC lyase. The gene base sequence according to the present invention can be used to increase the productivity of the existing FR-008 polyketides or produce new FR-008 polyketides, through modification of its parts.

      专利号:US-2009124012-A1
      优先权日:2007-08-08
      标题:Toxin/antitoxin systems and methods for regulating cellular growth, metabolic engineering and production of recombinant proteins
      发明人:NIKOLSKY YURI; BAEV MARK
      权利人:MAZEF BIOSCIENCES LLC
      摘要:The present invention provides compositions and method for regulating cellular growth and metabolism, intra- and extracellular enzymatic activities, and synthesis of endogenous and/or heterologous proteins, comprising the steps of cloning genes encoding an mRNA interferase (toxin) and its cognate antitoxin; expressing these proteins in a host cell from two separate constitutive or inducible promoters on one or more plasmid vectors or on a chromosome; and regulating the cellular growth and metabolism by controlling the ratio of toxin and antitoxin present in the host cell. Optionally, the method provides further steps of modifying an endogenous or heterologous gene of interest to substitute all mRNA recognition sequences with sequences that are not cleavable by the mRNA interferase being expressed without any change in the amino acid sequence of the protein encoded by the gene; and co-expressing the gene of interest in the same host cell.

      专利号:US-2008280855-A1
      优先权日:2005-06-22
      标 题 :Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles
      发明人:CHIESA MARIA VITTORIA; PALMER ANDREAS; BUHR WILM; ZIMMERMANN PETER JAN; BREHM CHRISTOF; SIMON WOLFGANG-ALEXANDER; POSTIUS STEFAN; KROMER WOLFGANG; ZANOTTI-GEROSA ANTONIO
      权利人:NYCOMED GMBH
      摘要:The invention relates to a process for the synthesis of compounds of the formula 1-a and compounds of the formula 1-b. n n n n n n n n n n The compounds of the formula 1-a and the compounds of the formula 1-b, in which the substituents R1, R2, R3, and Ar have the meanings indicated in the description, are valuable intermediates for the preparation of pharmaceutically active compounds.
      台州市瑞天医药化工有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.tianruipharm.com
      企业联系电话:86-576-88603301👤
      📞台州市瑞天医药化工有限公司 ⚠️参考联系方式
      联系人:陈雷
      电话:86-576-88603301

      传真:86-576-88603302
      邮箱:sales@tianruipharm.com
      通信地址: 浙江省台州市椒江区鑫泰街168号B楼
      邮编: 318000
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:浙江省台州市椒江区鑫泰街168号B楼
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      石家庄拓芬生物科技有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.tuofenshengwu.com
      企业联系电话:15032713787👤
      📞石家庄拓芬生物科技有限公司 ⚠️参考联系方式
      联系人:刘总
      电话:15032713787
      手机:15032713787
      传真:0953-5527128
      邮箱:331212767@qq.com
      通信地址: 河北省石家庄市晋州市桃工业区
      邮编: 052260
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:河北省石家庄市晋州市桃工业区
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      浙江思贤制药有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.sx-pharm.com
      电话: 0575-89298668👤
      📞浙江思贤制药有限公司 ⚠️参考联系方式

      销售电话:0575-89298668
      邮箱:jxb@sx-pharm.com
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      郑州佰宇药业有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.zzbaiyu.com
      企业联系电话:13938569199👤
      📞郑州佰宇药业有限公司 ⚠️参考联系方式
      联系人:陈经理
      电话:13938569199


      邮箱:13938569199@163.com
      通信地址: 河南省郑州市新郑市龙湖镇小刘桥百鸿机电市场C3区22号
      邮编: 450000
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:河南省郑州市新郑市龙湖镇小刘桥百鸿机电市场C3区22号
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      台州市博纳化工有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.tzbnchem.com
      企业联系电话:0576-88663272👤
      📞台州市博纳化工有限公司 ⚠️参考联系方式
      联系人:陈
      电话:0576-88663272

      传真:0576-88707069
      邮箱:sales@tzbnchem.com
      通信地址: 浙江省台州市椒江区外沙工业园区
      邮编: 318000
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:浙江省台州市椒江区外沙工业园区
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      第 1 / 1 页
      现货

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Available from http://www.ncbi.nlm.nih.gov/books/NBK548896/ doi: 10.1007/s40261-019-00808-2. Review. Erratum in: Clin Drug Investig. 2019 Jun 20;:. Available from http://www.ncbi.nlm.nih.gov/books/NBK540689/ doi: 10.1080/17512433.2017.1366311. Epub 2017 Aug 18. Review. doi: 10.1080/14656566.2017.1353079. Epub 2017 Jul 27. Review. e14. doi: 10.1016/j.ajog.2017.07.003. Epub 2017 Jul 8. Review. doi: 10.1080/14656566.2017.1309023. Epub 2017 Mar 27. Review. doi: 10.1371/journal.pone.0139017. eCollection 2015. Review. Erratum in: PLoS One. 2015;10(11):e0142276.
      9: Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother. 2008 Jun;42(6):827-35. doi: 10.1345/aph.1K675. Epub 2008 Apr 22. Review. doi: 10.1586/14787210.6.2.223. Review. Review. Review. Review. Review. Review. Review. Review. Japanese. Review. Review. Review.

      合成参考文献


      参考文献:10.1007/s10620-010-1140-6
      摘要:Day AS, Gearry RB. Rifaximin and Crohn’s Disease: A New Solution to an Old Problem Digestive Diseases and Sciences. 2010 Feb 13;55(4):877–9. doi: 10.1007/s10620-010-1140-6.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知